Paper20009774
Impact of postoperative radiation after esophagectomy for esophageal cancer.
Schreiber D and 7 others. J Thorac Oncol, 2010. Cited by 83 papers, by iCite.
Cite this record
ConductScience Library. Impact of postoperative radiation after esophagectomy for esophageal cancer. Papers, record 20009774. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20009774
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Esophageal Neoplasms | Major topic |
| Aged | |
| Chi-Square Distribution | |
| Esophagectomy | |
| Female | |
| Humans | |
| Male | |
| Neoplasm Invasiveness | |
| Neoplasm Staging | |
| Proportional Hazards Models | |
| Radiotherapy, Adjuvant | |
| Retrospective Studies | |
| SEER Program | |
| Survival Rate | |
| Treatment Outcome | |
| United States |
Source PubMed
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41987784 | Retrospective analysis of postoperative adjuvant therapy and survival in T4 esophageal squamous cell carcinoma: a dual-cohort study using SEER and Chinese multicenter data. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41987784 | PubMed |
| 41357221 | Efficacy and safety of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma patients with pathologic incomplete response after neoadjuvant immunochemotherapy: a retrospective cohort study. | Front Immunol | 2025 | https://conductscience.org/library/papers/41357221 | PubMed |
| 40061535 | Radiation therapy does not improve survival in patients who are upstaged after esophagectomy for clinical early-stage esophageal adenocarcinoma. | JTCVS Open | 2025 | https://conductscience.org/library/papers/40061535 | PubMed |
| 39831236 | Predictive and prognostic value of ACSL4 and GPX4 in patients with esophageal squamous cell carcinoma receiving post-operative radiotherapy. | J Thorac Dis | 2024 | https://conductscience.org/library/papers/39831236 | PubMed |
| 39511550 | Postoperative tumor bed radiation versus T-shaped field radiation in the treatment of locally advanced thoracic esophageal squamous cell carcinoma: a phase IIb multicenter randomized controlled trial. | BMC Med | 2024 | https://conductscience.org/library/papers/39511550 | PubMed |
| 39279953 | Patterns of regional lymph node metastasis predict postoperative overall survival and disease-free survival in locally advanced esophageal squamous cell carcinoma. | J Gastrointest Oncol | 2024 | https://conductscience.org/library/papers/39279953 | PubMed |
| 39259654 | Postoperative Radiotherapy in Curatively Resected Esophageal Squamous Cell Carcinoma With Occult Recurrent Laryngeal Nerve Lymph Node Metastasis. | Cancer Control | 2024 | https://conductscience.org/library/papers/39259654 | PubMed |
| 36750858 | Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9). | Radiat Oncol | 2023 | https://conductscience.org/library/papers/36750858 | PubMed |
| 36687238 | Esophageal Cancer: Whether and What Before or After Surgery? | Indian J Surg Oncol | 2022 | https://conductscience.org/library/papers/36687238 | PubMed |
| 36497360 | Effect of Adjuvant Radiation Dose on Survival in Patients with Esophageal Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36497360 | PubMed |
| 36117831 | Patterns of failure and long-term outcome of postoperative radiotherapy on the survival of patients with pathological T3N0M0 esophageal cancer. | Front Surg | 2022 | https://conductscience.org/library/papers/36117831 | PubMed |
| 36038943 | Effect of different surgical approaches on the prognosis of patients with postoperative radiotherapy for stage IIB-IVA esophageal squamous cancer. | World J Surg Oncol | 2022 | https://conductscience.org/library/papers/36038943 | PubMed |
| 36033454 | Development and validation of a deep learning model to predict survival of patients with esophageal cancer. | Front Oncol | 2022 | https://conductscience.org/library/papers/36033454 | PubMed |
| 34309117 | Postoperative Adjuvant Therapy Versus Surgery Alone for Stage IIB-III Esophageal Squamous Cell Carcinoma: A Phase III Randomized Controlled Trial. | Oncologist | 2021 | https://conductscience.org/library/papers/34309117 | PubMed |
| 34295813 | The Prognosis and Feasibility of Extensive Clinical Target Volume in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Clinical Trial. | Front Oncol | 2021 | https://conductscience.org/library/papers/34295813 | PubMed |
| 33553432 | Postoperative Adjuvant Therapy for Patients with pN+ Esophageal Squamous Cell Carcinoma. | Biomed Res Int | 2021 | https://conductscience.org/library/papers/33553432 | PubMed |
| 33376396 | Postoperative Radiotherapy for Thoracic Esophageal Carcinoma with Upfront R0 Esophagectomy. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/33376396 | PubMed |
| 33314798 | Conditional survival in patients with esophageal or gastroesophageal junction cancer after receiving various treatment modalities. | Cancer Med | 2021 | https://conductscience.org/library/papers/33314798 | PubMed |
| 33227662 | Delayed postoperative radiotherapy might improve the long-term prognosis of locally advanced esophageal squamous cell carcinoma. | Transl Oncol | 2021 | https://conductscience.org/library/papers/33227662 | PubMed |
| 33149667 | Timing of Adjuvant Chemoradiation in pT1-3N1-2 or pT4aN1 Esophageal Squamous Cell Carcinoma After R0 Esophagectomy. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/33149667 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20009774
GET https://conductscience.org/api/papers/v1/20009774/cited_by?page=2